Co-stimulation of PAFR and CD36 is required for oxLDL-induced human macrophages activation

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Rios, Francisco J O ^a   Koga, Mariana M ^a   Ferracini, Matheus ^a   Jancar, Sonia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; [2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE; BEPAFANT; CD36 ANTIGEN; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MACROPHAGE; MACROPHAGE ACTIVATION; MOLECULAR MECHANICS; MONOCYTE; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD36; CHEMOKINE CCL2; CHROMONES; ENZYME INHIBITORS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HEK293 CELLS; HUMANS; INTERLEUKIN-8; LIPOPROTEINS, LDL; MACROPHAGE ACTIVATION; MACROPHAGES; MODELS, BIOLOGICAL; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PLATELET MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84860530517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036632     Document Type: Article

References (32)

1. Hansson GK, Robertson AK, Soderberg-Naucler C, (2006) Inflammation and atherosclerosis. Annu Rev Pathol 1: 297-329.
2. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM, (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93: 229-240.
3. Glass CK, Witztum JL, (2001) Atherosclerosis. the road ahead. Cell 104: 503-516.
4. Nozaki S, Kashiwagi H, Yamashita S, Nakagawa T, Kostner B, et al. (1995) Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest 96: 1859-1865.
5. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, et al. (2000) Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 105: 1049-1056.
6. Febbraio M, Silverstein RL, (2007) CD36: implications in cardiovascular disease. Int J Biochem Cell Biol 39: 2012-2030.
7. Dobreva I, Waeber G, James RW, Widmann C, (2006) Interleukin-8 secretion by fibroblasts induced by low density lipoproteins is p38 MAPK-dependent and leads to cell spreading and wound closure. J Biol Chem 281: 199-205.
8. Senokuchi T, Matsumura T, Sakai M, Matsuo T, Yano M, et al. (2004) Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase mediate macrophage proliferation induced by oxidized low-density lipoprotein. Atherosclerosis 176: 233-245.
9. Marathe GK, Prescott SM, Zimmerman GA, McIntyre TM, (2001) Oxidized LDL contains inflammatory PAF-like phospholipids. Trends Cardiovasc Med 11: 139-142.
10. Svensjo E, Boschcov P, Ketelhuth DF, Jancar S, Gidlund M, (2003) Increased microvascular permeability in the hamster cheek pouch induced by oxidized low density lipoprotein (oxLDL) and some fragmented apolipoprotein B proteins. Inflamm Res 52: 215-220.
11. Rios FJ, Gidlund M, Jancar S, (2011) Pivotal role for platelet-activating factor receptor in CD36 expression and oxLDL uptake by human monocytes/macrophages. Cell Physiol Biochem 27: 363-372.
12. Riazy M, Chen JH, Yamamato Y, Yamamato H, Duronio V, et al. (2011) OxLDL-mediated survival of macrophages does not require LDL internalization or signalling by major pattern recognition receptors. Biochem Cell Biol 89: 387-395.
13. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, et al. (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11: 155-161.
14. Taketa K, Matsumura T, Yano M, Ishii N, Senokuchi T, et al. (2008) Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages. J Biol Chem 283: 9852-9862.
15. Zhao M, Liu Y, Wang X, New L, Han J, et al. (2002) Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL. APMIS 110: 458-468.
16. Ricci R, Sumara G, Sumara I, Rozenberg I, Kurrer M, et al. (2004) Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science 306: 1558-1561.
17. Prieto P, Cuenca J, Traves PG, Fernandez-Velasco M, Martin-Sanz P, et al. (2010) Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways. Cell Death Differ 17: 1179-1188.
18. D'Archivio M, Scazzocchio B, Filesi C, Vari R, Maggiorella MT, et al. (2008) Oxidised LDL up-regulate CD36 expression by the Nrf2 pathway in 3T3-L1 preadipocytes. FEBS Lett 582: 2291-2298.
19. Fritz JM, Dwyer-Nield LD, Malkinson AM, (2011) Stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting MEK and PI3K activation. Mol Cancer 10: 76.
20. Ketelhuth DF, Rios FJ, Wang Y, Liu H, Johansson ME, et al. (2011) Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses. Circulation 124: 2433-2443 2431-2437.
21. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M, (2002) Multiple control of interleukin-8 gene expression. J Leukoc Biol 72: 847-855.
22. Apostolakis S, Vogiatzi K, Amanatidou V, Spandidos DA, (2009) Interleukin 8 and cardiovascular disease. Cardiovasc Res 84: 353-360.
23. Inoue T, Komoda H, Nonaka M, Kameda M, Uchida T, et al. (2008) Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int J Cardiol 124: 319-325.
24. Dentan C, Lesnik P, Chapman MJ, Ninio E, (1996) Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells. Relevance to the inflammatory reaction in atherogenesis. Eur J Biochem 236: 48-55.
25. Brocheriou I, Stengel D, Mattsson-Hulten L, Stankova J, Rola-Pleszczynski M, et al. (2000) Expression of platelet-activating factor receptor in human carotid atherosclerotic plaques: relevance to progression of atherosclerosis. Circulation 102: 2569-2575.
26. Subbanagounder G, Leitinger N, Shih PT, Faull KF, Berliner JA, (1999) Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: in vitro and In vivo inhibition by WEB 2086. Circ Res 85: 311-318.
27. Triantafilou M, Gamper FG, Haston RM, Mouratis MA, Morath S, et al. (2006) Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 281: 31002-31011.
28. Rios FJ, Jancar S, Melo IB, Ketelhuth DF, Gidlund M, (2008) Role of PPAR-gamma in the modulation of CD36 and FcgammaRII induced by LDL with low and high degrees of oxidation during the differentiation of the monocytic THP-1 cell line. Cell Physiol Biochem 22: 549-556.
29. Carvalho MD, Vendrame CM, Ketelhuth DF, Yamashiro-Kanashiro EH, Goto H, et al. (2010) High-density lipoprotein inhibits the uptake of modified low- density lipoprotein and the expression of CD36 and FcgammaRI. J Atheroscler Thromb 17: 844-857.
30. Fremont L, Belguendouz L, Delpal S, (1999) Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci 64: 2511-2521.
31. Sakai H, Kaneshige H, Endoh M, (1982) Determination of LDL receptors on cultured lymphocytes using fluorescein-labeled LDL. Am J Clin Pathol 78: 58-62.
32. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.